Acute peritonitis as presentations of tuberculosis-associated immune reconstitution inflammatory syndrome in an HIV-infected man

American Journal of the Medical Sciences

Volumn 335, Issue 5, 2008, Pages 387-389

  Wu, Shih Wei ^a   Chen, Cheng Jueng ^b   Lin, Te Yu ^b   Wang, Ning Chi ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute peritonitis; HAART; Human immunodeficiency virus; Immune reconstitution inflammatory syndrome; Tuberculosis

Indexed keywords

EFAVIRENZ; ENFUVIRTIDE; ETHAMBUTOL; LAMIVUDINE; LEVOFLOXACIN; RIFABUTIN; STAVUDINE; STREPTOMYCIN;

ABSCESS DRAINAGE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEOSTOMY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LAPAROTOMY; LUNG TUBERCULOSIS; MALE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; THRUSH; TREATMENT DURATION; TUBERCULOUS PERITONITIS; WESTERN BLOTTING; ACUTE DISEASE; AIDS RELATED COMPLEX; IMMUNOLOGY; PERITONITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUBERCULOSIS;

ACUTE DISEASE; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MALE; PERITONITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUBERCULOSIS;

EID: 45549083971     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318149e6de     Document Type: Article

References (10)

1. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005;5:361-73.
2. Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis 2006;19:20-5.
3. Carcelain G, Debre P, Autran B. Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol 2001;13:483-8.
4. Cheng VC, Yuen KY, Chan WM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000;30:882-92.
5. Michailidis C, Pozniak AL, Mandalia S. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther 2005;10:417-22.
6. Shelburne SA, Visnegarwala F, Darcourt J. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406.
7. Akgun Y. Intestinal and peritoneal tuberculosis: changing trends over 10 years and a review of 80 patients. Can J Surg 2005;48:131-6.
8. Cheng VC, Yam WC, Woo PC. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22:597-602.
9. Breen RA, Smith CJ, Bettinson H. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 2004;59:704-7.
10. Schiffer JT, Sterling TR. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr 2007;44:229-34.